中文簡(jiǎn)體丨English
Log in to the enterprise email Click to enter
【Drug Name】
Generic Name:Octreotide Acetate Injection
English Name:Octreotide Acetate Injection
Pinyin:Cusuan Aoqutai Zhusheye
【Ingredients】
The main active ingredient of this product is Octreotide Acetate.
【Indications】
1.To control symptoms and reduce plasma levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in patients with acromegaly whose condition cannot be adequately controlled by surgery or radiotherapy. Octreotide can also be used in patients with acromegaly who are unable or unwilling to undergo surgery, or during the interim period before radiotherapy becomes effective.2. To alleviate symptoms associated with functional gastro-entero-pancreatic (GEP) endocrine tumors, such as carcinoid tumors presenting with carcinoid syndrome.3. Octreotide is not an anti-cancer medication and does not cure these patients. 4. For the prevention of complications following pancreatic surgery. 5. For the emergency treatment of bleeding from gastroesophageal varices in patients with cirrhosis, to stop bleeding and prevent rebleeding. Octreotide should be used in combination with specific treatments such as endoscopic sclerotherapy.
【Manufacturer】
Company Name:Fuan Pharmaceutical Group Hubei Renming Pharmaceutical Co., Ltd
Address:No.1, Qijiashan, Baiquan, Dongxihu District, Wuhan City, Hubei Provice, P.R.C
About Fuan
Investor Relations
Contact Us
WeChat Official Account of Fuan Pharmaceutical
Subsidiary Introduction
Address: No. 2 Huangyang Road, Yubei District, Chongqing
Postal Code: 401121
© 2025 Fuan Pharmaceutical (Group) Co., Ltd
渝網(wǎng)藥信備字[2025]00173號(hào) 渝ICP備2022009953號(hào)-1 渝公網(wǎng)安備50011502000349號(hào)